Health Ministry and regulatory authority Directory Product related
information
Pre and post approval
national fee Directory 
National Law and ActPharmacopoeia CTD and eCTD
acceptability
FP stability data
requirments 
Expected authority
review timelines 
package labeling
requirements 
National good Practice
(GxP) Directory
Certificate of
Pharmaceutical Products CPP
Geographical details
Country
Name 
Geographical RegionOther Regional GroupCollaborative Recognition
procedure (CRP)
Health Authority NameHA contact information Market LeaderRegulatory Agency Home page linkMinistry of Health home page linkUpcoming Regulation FlagHA
Guideline/Resolution/Regulation/ page link
HA Variation Guideline link
page 
HA Renewal Guideline link
page 
HA Registration Guideline link
page 
Reference Authority/AgencyRegulation Reference SRA recognition AcceptabilityWHO Pre Qualification (Member
states) CRP
Procedure Typeapplication type Application form Products type Regulatory Activity acceptedCountry Filing RequiredDuration of registration Renewal required (Yes/No) Submission LanguagecurrencyCTA FeesScientific advice feesapplication feesRenewal Fessvariation feesLine extension feesTransfer feeDrug Law original and fiest
pulication date 
Decree and regulation of reference
Doc 
Regulatory summery National PharmacopoeiaEdition last and current Other Pharmacopoeia accepted Pharmacopoeia websiteCTD acceptability Yes/NOeCTD acceptability Yes/NoOnline electronic submission
(agency portal, email address etc)
Electronic submission (CD/DVD/Pen
drive)
climate zone Long term (real time) testing
condition
Minimum time periodtime points (realtime)Minimum number of bacth accelrated testing conditionminimum time period (acc)time point (ACC)Intermedicate testing conditionminimum time period (INt)time point (Int)standard validation time for drug
application
standard review time for drug
application
priority/accelerated review
approval availability
expected regulatory authority time
– priority/accelerated
Language MAH informationMA registration numberMfg informationMfg Date Legal supply statusPrice DetailsIdentification and
Authenticity 
traceability GMPGLPGDPGCPGVPCPP Issuing authorityWHO formatTurnaround timeFees for COPPLanguagefor which regulatory submission
CPP required
need for legalizationNeed for sample /label together
with CPP submission 
AreaCapital/Major CityOfficial languagePopulationDescription
ZambiaEEMEASouthern
African Development Community (SADC)
ZAZIBONAZambia
Medicines Regulatory Authority
ZAMRA Head Office
Zambia Medicines Regulatory Authority
Plot No. 2350/M
P. O Box 31890
Off Kenneth Kaunda International Airport Road
Lusaka , Zambia

Phone: +260 211 432 350
Phone: +260 211 432 351
South
africa 
https://www.zamra.co.zm/https://www.moh.gov.zm/guidleine
on tracibility of medicine
https://www.zamra.co.zm/guidelines/https://www.zamra.co.zm/wp-content/uploads/2023/08/Amendment-for-Marketing-Authorisation-Human-Medicines.pdfhttps://www.zamra.co.zm/wp-content/uploads/2023/05/Guidelines-on-Renewal-for-Marketing-Authorisation-of-Medicines-and-Allied-Substances-ZAMRA_2019v2.docxhttps://www.zamra.co.zm/wp-content/uploads/2023/08/Application-for-Marketing-Authorisation-CTD-Format-Human-Medicines.pdfSADCWHO,
Thai Food and Drug Administration
YesYesnational
procedure
Finished
Pharmaceutical products 
YesGeneric Registration,
renewal, Amendments
Yes5 YearsYesEnglishZambian
Kwacha
Human
Clinical Trial Certificate involving Investigational Products
without Marketing Authorisation – US$ 3,000.00,
Human Clinical Trial Certificate involving Investigational Products with
Marketing Authorisation – US$ 2,500.00
US$
400.00
Generics-
US$ 2,000.00, New Chemical Entities – US$ 2,800.00, Biologicals – US$
2,800.00, Abridged Applications -US$ 1,700.00
Human
Medicines Generics, Human Medicines NCEs, Biologicals, – US$ 1,200.00,
Minor
amendment – US$ 100.00, Major amendment – US$ 500.00
Not specifiedNot specifiedthe Medicines and Allied
Substances Act No. 3 of 2013
Not specifiedThe
Zambia Medicines Regulatory Authority formally the Pharmaceutical Regulatory
Authority is a Statutory National Medicines Regulatory Body in Zambia
established under an Act of Parliament, the Medicines and Allied Substances
Act No. 3 of 2013 of the Laws of Zambia to regulate and control the
Manufacture, Importation, Storage, Distribution, Supply, Sale and Use of
Medicines and Allied Substances. The main objective of the Authority is to
ensure that all Medicines and Allied Substances being made available to the
Zambian people consistently meet the set standards of Quality, Safety and
Efficacy.

The history of medicines regulation in Zambia dates back to 1941 when the
Pharmacy and Poisons Act, Chapter 299 of the Laws of Zambia was first enacted.
This Act was to provide for the control of the profession of pharmacy and
trade in drugs and poisons.
Not specifiedNot specifiedBP,EP,USP,JP
and Int Ph.
Not specifiedYesNoNoYesZone
IVA: Hot/humid.
•Zone IVB: Hot/very humid
30/65
and 30/75 both accepted 
12
Months 
first
years every 3 months, then 2nd years every 6 month and after that yearly upto
propose shelf life
340/7560,3,6Not required Not required Not required Not specified9
months
yes3-6
months
EnglishYesYesYesYesYesYesYesYesYesNot
specified 
YesNot
specified 
Not
specified 
YesYesNot
specified 
NOEnglishRegistration,
renewal
NOYes7,52,618LusakaEnglish1,70,94,130Zambia,
officially the Republic of Zambia, is a landlocked country at the crossroads
of Central, Southern and East Africa. It is typically referred to being in
South-Central Africa or Southern Africa. It is bordered to the north by the
Scroll to Top